Chicago (1)

Cleveland (1)

Medford (1)

Milwaukee (1)

New Brunswick (1)

Adult Burkitt Lymphoma (1)

B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma (1)

Diffuse Large B-Cell Lymphoma (1)

MYC Gene Mutation (1)

Plasmablastic Lymphoma (1)

Active, not recruiting (1)

phase 1/phase 2 (1)

Northwestern University (1)

Millennium Pharmaceuticals, Inc. (1)

National Cancer Institute (NCI) (1)

biological (1)

drug (1)

other (1)

Other (1)

Interventional (1)

myc gene mutation

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Feb 17, 2022